Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,413 | 1,181 | 99.3% |
| Education | $118.37 | 12 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,108 | 124 | $0 (2024) |
| Novo Nordisk Inc | $2,034 | 152 | $0 (2024) |
| Lilly USA, LLC | $1,783 | 138 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,291 | 88 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,259 | 71 | $0 (2024) |
| PFIZER INC. | $749.79 | 67 | $0 (2024) |
| Amgen Inc. | $712.96 | 45 | $0 (2024) |
| Amarin Pharma Inc. | $688.85 | 63 | $0 (2022) |
| Merck Sharp & Dohme LLC | $667.51 | 56 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $599.62 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,476 | 83 | AstraZeneca Pharmaceuticals LP ($301.65) |
| 2023 | $2,082 | 120 | Lilly USA, LLC ($269.35) |
| 2022 | $2,238 | 137 | Lilly USA, LLC ($321.57) |
| 2021 | $2,423 | 163 | Lilly USA, LLC ($294.20) |
| 2020 | $2,283 | 157 | AstraZeneca Pharmaceuticals LP ($368.89) |
| 2019 | $2,527 | 192 | Novo Nordisk Inc ($360.73) |
| 2018 | $2,241 | 161 | GlaxoSmithKline, LLC. ($308.24) |
| 2017 | $2,261 | 180 | AstraZeneca Pharmaceuticals LP ($359.41) |
All Payment Transactions
1,193 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: VACCINES | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Diabetes Care | ||||||
| 12/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.68 | General |
| Category: PAIN | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: Respiratory | ||||||
| 10/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: PAIN | ||||||
| 10/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 10/01/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: PAIN | ||||||
| 09/27/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.62 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Obesity | ||||||
| 09/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $75.14 | General |
| Category: Hematology | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 376 | 813 | $149,821 | $36,908 |
| 2022 | 14 | 441 | 837 | $210,891 | $50,857 |
| 2021 | 12 | 553 | 1,008 | $189,312 | $45,724 |
| 2020 | 12 | 593 | 894 | $141,357 | $35,073 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 290 | $110,450 | $24,464 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 57 | 57 | $21,873 | $7,275 | 33.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $4,406 | $1,507 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $4,590 | $1,067 | 23.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $2,200 | $726.18 | 33.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 38 | 38 | $2,090 | $688.94 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,913 | $619.71 | 32.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 50 | $2,094 | $505.10 | 24.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 15 | $105.00 | $33.00 | 31.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 264 | $100.32 | $22.56 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 373 | $143,232 | $29,733 | 20.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $25,872 | $8,598 | 33.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $11,119 | $3,832 | 34.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 35 | $6,853 | $2,327 | 34.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $5,533 | $1,829 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 29 | $7,909 | $1,577 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,792 | $965.50 | 53.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 12 | $1,896 | $505.96 | 26.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 13 | 15 | $3,315 | $457.90 | 13.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 42 | $1,806 | $444.68 | 24.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $737.94 | $400.80 | 54.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $616.00 | $122.74 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 22 | $154.00 | $48.99 | 31.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 156 | $56.16 | $13.93 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 327 | $127,290 | $28,360 | 22.3% |
About Dr. David Dunn, MD
Dr. David Dunn, MD is a Family Medicine healthcare provider based in Crowley, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275560088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dunn, MD has received a total of $17,531 in payments from pharmaceutical and medical device companies, with $1,476 received in 2024. These payments were reported across 1,193 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($17,413).
As a Medicare-enrolled provider, Dunn has provided services to 1,963 Medicare beneficiaries, totaling 3,552 services with total Medicare billing of $168,561. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Crowley, TX
- Active Since 06/27/2006
- Last Updated 05/30/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275560088
Products in Payments
- FARXIGA (Drug) $1,617
- JARDIANCE (Drug) $1,211
- Vascepa (Drug) $688.85
- Ozempic (Drug) $668.19
- TRULICITY (Drug) $631.64
- TRELEGY ELLIPTA (Drug) $533.85
- MOUNJARO (Drug) $529.23
- JANUVIA (Drug) $455.84
- CONTRAVE (Drug) $436.09
- OXTELLAR XR (Drug) $411.51
- EMGALITY (Drug) $373.34
- NURTEC ODT (Drug) $344.51
- Saxenda (Drug) $330.34
- TRINTELLIX (Drug) $293.02
- VRAYLAR (Drug) $287.31
- Wegovy (Drug) $269.27
- XYOSTED (Drug) $268.07
- UBRELVY (Drug) $268.04
- Kerendia (Drug) $224.43
- SHINGRIX (Biological) $222.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Crowley
Daniel Chadwick, Md, MD
Family Medicine — Payments: $14,369
Sheila Horsley, M.d, M.D
Family Medicine — Payments: $8,086
Dr. Karrie Kilgore, M.d, M.D
Family Medicine — Payments: $5,201
Dr. Paul Stringfellow, M.d, M.D
Family Medicine — Payments: $4,966
Stephen Cannon, Md, MD
Family Medicine — Payments: $3,036
Dr. Nancy Walker, M.d, M.D
Family Medicine — Payments: $2,762